2024-18264. Medical Devices; Immunology and Microbiology Devices; Classification of the Device To Detect and Identify Selected Microbial Agents That Cause Acute Febrile Illness
Table 1—Device To Detect and Identify Selected Microbial Agents That Cause Acute Febrile Illness Risks and Mitigation Measures
Identified risks Mitigation measures Risk of an inaccurate test result (false positive or false negative result) leading to improper patient management Certain labeling information, including certain limiting statements and performance information; Certain design verification and validation, including certain analytical studies and clinical studies; and Use of certain specimen collection devices. Misinterpretation of test results leading to misdiagnosis and associated risk of false test results Certain labeling information, including certain limiting statements and performance information; and Certain design verification and validation, including certain analytical studies and clinical studies. Failure to correctly operate the device leading to inaccurate test results Certain labeling information, including certain limiting statements and performance information; Certain design verification and validation, including certain analytical studies and clinical studies; and Use of certain specimen collection devices.
Document Information
- Effective Date:
- 8/16/2024
- Published:
- 08/16/2024
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final amendment; final order.
- Document Number:
- 2024-18264
- Dates:
- This order is effective August 16, 2024. The classification was applicable on November 20, 2020.
- Pages:
- 66556-66558 (3 pages)
- Docket Numbers:
- Docket No. FDA-2024-N-3358
- Topics:
- Biologics, Laboratories, Medical devices
- PDF File:
- 2024-18264.pdf
- CFR: (1)
- 21 CFR 866